Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q3 2014 (← Previous) (Next →)
Filing Date: Nov 14, 2014
Total Value: $486M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| PBYI | PUMA BIOTECHNOLOGY INC | 507,500 | $121M | 24.9% | $146.25 | +40.4% | COM | 74587V107 |
| — | RECEPTOS INC | 748,700 | $46.5M | 9.6% | $43.18 | — | COM | 756207106 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 100,000 | $16.06M | 3.3% | $150.52 | +2.1% | SHS USD | G50871105 |
| — | DYAX CORP | 1,500,000 | $15.18M | 3.1% | $7.54 | — | COM | 26746E103 |
| — | KERYX BIOPHARMACEUTICALS | 1,000,000 | $13.75M | 2.8% | $13.75 | — | COM | 492515101 |
| — | KARYOPHARM THERAPEUTICS INC | 385,000 | $13.45M | 2.8% | $33.09 | — | COM | 48576U106 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 850,000 | $13.32M | 2.7% | $14.65 | +2.0% | COM | 64125C109 |
| — | ARROWHEAD RESH CORP | 900,000 | $13.29M | 2.7% | $10.85 | — | COM NEW | 042797209 |
| — | ACCELERON PHARMA INC | 400,000 | $12.1M | 2.5% | $32.10 | — | COM | 00434H108 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,100,000 | $10.76M | 2.2% | $9.67 | +26.8% | COM | 09058V103 |
| AKBA | AKEBIA THERAPEUTICS INC | 400,000 | $8.852M | 1.8% | $24.08 | -4.6% | COM | 00972D105 |
| — | OVASCIENCE INC | 516,200 | $8.569M | 1.8% | $16.60 | — | COM | 69014Q101 |
| — | TESARO INC | 300,000 | $8.076M | 1.7% | $28.24 | — | COM | 881569107 |
| DXCM | DEXCOM INC | 200,000 | $7.998M | 1.6% | $7.91 | +29.2% | COM | 252131107 |
| BMY | BRISTOL MYERS SQUIBB CO | 150,000 | $7.677M | 1.6% | $34.21 | 0.0% | COM | 110122108 |
| OMER | OMEROS CORP | 547,900 | $6.969M | 1.4% | $12.47 | +12.3% | COM | 682143102 |
| — | CHIMERIX INC | 250,000 | $6.905M | 1.4% | $19.16 | — | COM | 16934W106 |
| — | SYNAGEVA BIOPHARMA CORP | 100,000 | $6.878M | 1.4% | $68.78 | — | COM | 87159A103 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 120,000 | $6.792M | 1.4% | $46.32 | +8.6% | COM | 90400D108 |
| — | NOVAVAX INC | 1,500,000 | $6.255M | 1.3% | $4.95 | — | COM | 670002104 |
| AGIO | AGIOS PHARMACEUTICALS INC | 100,000 | $6.135M | 1.3% | $43.10 | 0.0% | COM | 00847X104 |
| HRTX | HERON THERAPEUTICS INC | 700,000 | $5.831M | 1.2% | $11.95 | -22.0% | COM | 427746102 |
| ARDX | ARDELYX INC | 388,700 | $5.523M | 1.1% | $14.46 | 0.0% | COM | 039697107 |
| PTCT | PTC THERAPEUTICS INC | 125,000 | $5.501M | 1.1% | $26.39 | +18.6% | COM | 69366J200 |
| — | ACELRX PHARMACEUTICALS INC | 1,000,000 | $5.49M | 1.1% | $9.56 | — | COM | 00444T100 |
| — | NEKTAR THERAPEUTICS | 450,000 | $5.432M | 1.1% | $12.07 | — | COM | 640268108 |
| SGMO | SANGAMO BIOSCIENCES INC | 500,000 | $5.393M | 1.1% | $17.13 | -23.7% | COM | 800677106 |
| — | CHINA BIOLOGIC PRODS INC | 95,000 | $5.126M | 1.1% | $44.47 | — | COM | 16938C106 |
| EGRX | EAGLE PHARMACEUTICALS INC | 400,000 | $5.06M | 1.0% | $13.58 | -8.7% | COM | 269796108 |
| — | PORTOLA PHARMACEUTICALS INC | 200,000 | $5.056M | 1.0% | $25.84 | — | COM | 737010108 |
| — | QUOTIENT LTD | 500,000 | $4.715M | 1.0% | $8.36 | — | SHS | G73268107 |
| SRNE | SORRENTO THERAPEUTICS INC | 1,000,000 | $4.52M | 0.9% | $10.01 | -46.3% | COM NEW | 83587F202 |
| ALKS | ALKERMES PLC | 100,000 | $4.287M | 0.9% | $47.58 | -5.8% | SHS | G01767105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 50,000 | $3.905M | 0.8% | $59.65 | +8.1% | COM | 02043Q107 |
| — | VERSARTIS INC | 200,000 | $3.798M | 0.8% | $28.04 | — | COM | 92529L102 |
| — | ROCKWELL MED INC | 400,000 | $3.656M | 0.8% | $12.66 | — | COM | 774374102 |
| — | ARRAY BIOPHARMA INC | 1,000,000 | $3.57M | 0.7% | $5.01 | — | COM | 04269X105 |
| — | IMMUNE DESIGN CORP | 200,000 | $3.532M | 0.7% | $17.66 | — | COM | 45252L103 |
| — | NANOSTRING TECHNOLOGIES INC | 300,000 | $3.282M | 0.7% | $20.65 | — | COM | 63009R109 |
| — | GLYCOMIMETICS INC | 472,300 | $3.278M | 0.7% | $16.33 | — | COM | 38000Q102 |
| — | KINDRED BIOSCIENCES INC | 350,000 | $3.238M | 0.7% | $11.93 | — | COM | 494577109 |
| — | CLOVIS ONCOLOGY INC | 70,000 | $3.175M | 0.7% | $60.27 | — | COM | 189464100 |
| — | KITE PHARMA INC | 100,000 | $2.85M | 0.6% | $28.50 | — | COM | 49803L109 |
| — | GENVEC INC | 1,329,300 | $2.765M | 0.6% | $2.65 | — | COM NEW | 37246C307 |
| — | AUSPEX PHARMACEUTICALS INC | 100,000 | $2.567M | 0.5% | $30.76 | — | COM | 05211J102 |
| GALT | GALECTIN THERAPEUTICS INC | 450,400 | $2.266M | 0.5% | $13.23 | -41.1% | COM NEW | 363225202 |
| — | AVALANCHE BIOTECHNOLOGIES IN | 65,000 | $2.222M | 0.5% | $34.18 | — | COM | 05337G107 |
| — | RECRO PHARMA INC | 700,000 | $2.072M | 0.4% | $6.07 | — | COM | 75629F109 |
| — | AGENUS INC | 650,000 | $2.022M | 0.4% | $3.17 | — | COM NEW | 00847G705 |
| — | AQUINOX PHARMACEUTICALS INC | 300,000 | $1.998M | 0.4% | $12.15 | — | COM | 03842B101 |
| — | ZS PHARMA INC | 50,000 | $1.962M | 0.4% | $39.24 | — | COM | 98979G105 |
| — | ALDER BIOPHARMACEUTICALS INC | 150,000 | $1.902M | 0.4% | $20.07 | — | COM | 014339105 |
| — | CERULEAN PHARMA INC | 450,000 | $1.899M | 0.4% | $5.80 | — | COM | 15708Q105 |
| — | CELSUS THERAPEUTICS PLC | 244,500 | $1.491M | 0.3% | $6.26 | — | SPONSORED ADR NE | 15119A202 |
| — | REGULUS THERAPEUTICS INC | 200,000 | $1.366M | 0.3% | $8.21 | — | COM | 75915K101 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $1.177M | 0.2% | $2.22 | — | COM NEW | 15117F203 |
| — | ADVAXIS INC | 350,000 | $1.176M | 0.2% | $3.36 | — | COM NEW | 007624208 |
| — | APPLIED GENETIC TECHNOL CORP | 60,600 | $1.128M | 0.2% | $23.10 | — | COM | 03820J100 |
| — | AGILE THERAPEUTICS INC | 150,000 | $1.095M | 0.2% | $8.72 | — | COM | 00847L100 |
| — | MINERVA NEUROSCIENCES INC | 175,000 | $1.059M | 0.2% | $6.05 | — | COM | 603380106 |
| — | BRISTOL MYERS SQUIBB CO | 5,000 | $985K | 0.2% | $197.00 | — | CALL | 110122908 |
| — | CURIS INC | 600,000 | $846K | 0.2% | $1.86 | — | COM | 231269101 |
| — | SCYNEXIS INC | 100,000 | $739K | 0.2% | $8.02 | — | COM | 811292101 |
| — | CELLECTAR BIOSCIENCES INC | 530,000 | $318K | 0.1% | $0.60 | — | *W EXP 08/19/201 | 15117F112 |
| — | SAGE THERAPEUTICS INC | 10,000 | $315K | 0.1% | $31.50 | — | COM | 78667J108 |